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The type VI secretion system (T6SS) is crucial in inter-
bacterial competition and is a virulence determinant
ofmanyGram-negative bacteria. Several T6SS effec-
tors are covalently fused to secreted T6SS structural
components such as the VgrG spike for delivery into
target cells. In Pseudomonas aeruginosa, the
VgrG2b effector was previously proposed tomediate
bacterial internalization into eukaryotic cells. In this
work, we find that the VgrG2b C-terminal domain
(VgrG2bC-ter) elicits toxicity in the bacterial peri-
plasm, counteracted by a cognate immunity protein.
We resolve the structure of VgrG2bC-ter and confirm it
is a member of the zinc-metallopeptidase family of
enzymes. We show that this effector causes mem-
brane blebbing at midcell, which suggests a distinct
type of T6SS-mediated growth inhibition through
interference with cell division, mimicking the impact
of b-lactam antibiotics. Our study introduces a
further effector family to the T6SS arsenal and dem-
onstrates that VgrG2b can target both prokaryotic
and eukaryotic cells.
INTRODUCTION
Protein secretion systems are used by bacteria to interact with
other organisms and exploit the local environment (Filloux,C
This is an open access article und2011). Proteins transported by these systems shape the
behavior of polymicrobial communities and interfere with eu-
karyotic cells. The type VI secretion system (T6SS) delivers
effector proteins into both bacterial and eukaryotic targets in a
contact-dependent manner (Ho et al., 2014; Jiang et al., 2014)
and has been proposed to be involved in the acquisition of public
goods such as metal ions (Lin et al., 2017; Si et al., 2017a,
2017b). Although the T6SS can manipulate signaling pathways
and the cytoskeleton of eukaryotes (Aubert et al., 2016; Chen
et al., 2017; Hachani et al., 2016), it appears to be predominantly
involved in bacterial antagonism, in which toxin delivery into
neighboring cells elicits growth inhibition and cell death (Allsopp
et al., 2017; Hachani et al., 2014; MacIntyre et al., 2010; Russell
et al., 2014).
The T6SS is a contractile injection system anchored in the
bacterial envelope, evolutionarily related to bacteriophage tails
(Leiman et al., 2009; Pukatzki et al., 2007). A conformational
change of the T6SS baseplate platform is thought to trigger the
contraction of a cytoplasmic sheath, expelling a spear-like struc-
ture to puncture a target cell membrane (Cianfanelli et al., 2016;
Salih et al., 2018; Wang et al., 2017). The spear is composed of a
stack of Hcp rings capped with a spike complex of a trimer of
VgrG proteins and a PAAR protein tip (Mougous et al., 2006;
Renault et al., 2018; Shneider et al., 2013). The trimeric VgrG
complex shares extensive structural homologywith the bacterio-
phage gp27-gp5 tail spike, which also serves as a membrane
puncturing device (Hachani et al., 2011; Leiman et al., 2009; Pu-
katzki et al., 2007). The spear is decorated with cargo effector
proteins, often associating through non-covalent interactions
with the structural components (Cianfanelli et al., 2016; Jiangell Reports 29, 187–201, October 1, 2019 ª 2019 The Authors. 187
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Figure 1. H2-T6SS-Dependent Secretion of the Evolved VgrG2b
(A) vgrG2b locus of P. aeruginosa PAO1. The vgrG2b gene is colored according to its domain architecture shown in (B). PA0261, shown in blue, is also char-
acterized in this work. Scale bar represents 5 kb.
(B) Schematic of the domain organization of the VgrG2b protein. The N-terminal region (yellow) forms the spike-like structure of the T6SS spear, composed of the
gp27- and gp5-like domains and likely the DUF2345 domain. The TTR domain is a putative protein-protein interaction domain. The C-terminal domain has an
HEXXH motif typically found in the catalytic site of metallopeptidases.
(C) Model of the tertiary structure of the DUF2345 domain of the VgrG2b trimer, with the protomers depicted in red, yellow, and teal.
(D) Immunoblot demonstrating secretion of VgrG2b by the H2-T6SS. Red arrows indicate the band corresponding to the VgrG2b protein to distinguish it from the
non-specific bands recognized by the polyclonal antibody. Anti-RpoB recognizes the b subunit of RNA polymerase and is employed as a lysis control, while anti-
LasB detects a secreted type II secretion system (T2SS) effector protein, used as a supernatant loading control. Image is representative of three independent
experiments.
Uncropped immunoblots and gels of all figures are provided in Data S1.et al., 2019; Shneider et al., 2013). Besides these cargo effectors,
effector domains can be fused to a Hcp, VgrG, or PAAR protein.
Examples of these specialized effectors, also called evolved
spear components, include the NAD(P)+-hydrolyzing toxin Tse6
from Pseudomonas aeruginosa or the peptidoglycan hydrolase
extension of VgrG3VC of Vibrio cholerae (Brooks et al., 2013; Ha-
chani et al., 2014; Whitney et al., 2015).
P. aeruginosa possesses three T6SSs, designated H1-, H2-,
and H3-T6SS (Mougous et al., 2006). Although the H1-T6SS
is well characterized as an antibacterial weapon, our under-
standing of the effectors secreted by the H2-T6SS is still in its
infancy. Two phospholipases, PldA and Tle4, are secreted by
this system into both bacterial and eukaryotic cells and have
consequently been designated trans-kingdom effectors (Jiang
et al., 2014, 2016). In addition, the antibacterial nuclease
effector TseT and the evolved VgrG2b have been linked to
this system (Burkinshaw et al., 2018; Sana et al., 2015). VgrG2b
is involved in the internalization of P. aeruginosa PAO1 into
epithelial cells, because uptake of a vgrG2b mutant is
decreased versus the wild-type strain (Sana et al., 2015). Infec-
tion of epithelial cells expressing vgrG2b displays enhanced
internalization not only of wild-type P. aeruginosa but also of
an H2-T6SS-deficient strain. Elements of the host cytoskeleton
are co-opted for invasion, because chemical inhibition of
actin and microtubule polymerization blocks bacterial uptake.
Furthermore, interactome analysis of VgrG2b ectopically ex-
pressed in host cells identified components of the g-tubulin188 Cell Reports 29, 187–201, October 1, 2019ring complex (gTuRC) as binding partners of this evolved spike
protein. Despite the microtubule network being implicated in
P. aeruginosa invasion, the mechanism of this process remains
to be understood.
In this study, we report that VgrG2b represents an evolved
trans-kingdom T6SS effector. We provide evidence that VgrG2b
is directly secreted by the H2-T6SS and that the VgrG2b C-ter-
minal domain (VgrG2bC-ter) possesses antibacterial activity. We
show that this domain, the structure of which we present in
this work, is a member of a widespread family of metallopepti-
dases eliciting toxicity in the bacterial periplasm and that it can
be neutralized by a cognate immunity protein. The toxicity of
VgrG2bC-ter results in profound morphological anomalies char-
acterized by blebbing of the bacterial membrane at the site of
septation, a phenotype reminiscent of inhibition of the cell divi-
sion machinery by b-lactam antibiotics.
RESULTS
VgrG2b Is an Evolved VgrG Protein Secreted by the
H2-T6SS
VgrG2b is encoded in the hcpC locus with the hypothetical pro-
tein PA0261 and the effector-immunity module Tle3-Tli3 (type VI
lipase effector 3-type VI lipase immunity 3) (Figure 1A), where
Tle3 is a predicted phospholipase (Barret et al., 2011; Wood
et al., 2019). As such, it is not genetically linked to any T6SS
core gene clusters. Beyond its canonical trimeric spike-forming
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Figure 2. Structure of the VgrG2b Metallopeptidase Domain
(A) Cartoon representation of the metallopeptidase fold of the VgrG2b C-ter-
minal domain. The zinc ion is modeled in the catalytic center as a gray sphere.
Elements of secondary structure are labeled (a, a helix; b, b strand) and the
three catalytic residues are shown as sticks. See also Figure S1 and Tables S1
and S2.
(B) Comparison of the active site of the VgrG2b metallopeptidase domain (left)
with that of angiotensin-converting enzyme 2 (right) from Homo sapiens (PDB:
3D0G). The coordinating residues of the gray zinc ion are labeled. In
VgrG2bC-ter, H935, E936, and H939 form the catalytic triad, and E983 is the
additional ligand; the corresponding residues in human angiotensin-convert-
ing enzyme 2 are H374, E375, H378, and E736, respectively.region containing gp27- and gp5-like domains, VgrG2b harbors
a C-terminal extension, rendering it an evolved VgrG protein
(Figure 1B). VgrG2b also contains a DUF2345 domain, predicted
to adopt a b-helical fold similar to the gp5-like domain (Fig-
ure 1C), which can be considered an extension of the spike re-
gion (Sana et al., 2015). The C-terminal portion of the VgrG2b
spike protein is predicted to function as a metallopeptidase
because of the presence of a signature zinc-binding HEXXH
motif (Figure 1B). Bioinformatic analysis of the linker region be-
tween the DUF2345 and the metallopeptidase domains reveals
a transthyretin (TTR)-like fold, implicated in protein-protein inter-
actions. Indeed, C-terminal TTR folds have been described in
PAAR and VgrG proteins, with that of VgrG1 in enteroaggrega-
tive Escherichia coli empirically shown to be important in thedelivery of the cargo effector Tle1 (Flaugnatti et al., 2016;
Shneider et al., 2013).
A previous study determined that VgrG2b and the H2-T6SS
are required in invasion of epithelial cells during infection, but
no H2-T6SS-dependent secretion of VgrG2b was effectively
demonstrated (Sana et al., 2015). We have recently described
in vitro conditions in which the H2-T6SS is active and established
that the Hcp2 tail tube protein, encoded by at least one of
the identical paralogs hcpA, hcpB, hcpC, and hcp2 in
P. aeruginosa PA14, is secreted by this system (Allsopp et al.,
2017). Here, we employed antibodies raised against peptides
within the metallopeptidase domain of VgrG2b to probe for
this spike protein in the supernatant of P. aeruginosa cultures
grown in H2-T6SS-conducive conditions. VgrG2b and Hcp2
are detected in the extracellular milieu of the parental strain
(PAO1DrsmA); however, deletion of the tssE2 gene, encoding
an H2-T6SS baseplate component, abolishes their secretion
(Figure 1D). Complementation with tssE2 in trans partially re-
stores secretion of VgrG2b and Hcp2.
Altogether, this confirms that VgrG2b is secreted in an H2-
T6SS-dependent manner. Although the H2-T6SS locus of
P. aeruginosa PAO1 lacks genes encoding the spike and tube
proteins of the T6SS spear assembly, this result highlights that
the H2-T6SS supports the secretion of several of distally en-
coded effectors (Barret et al., 2011; Hachani et al., 2011).
Crystal Structure of VgrG2b C-Terminal Effector
Domain
Next, we purified VgrG2bC-ter (residues 770–1,019) to initiate
structural analysis. We solved the structure of VgrG2bC-ter, en-
compassing residues 833–1,019, using crystals of both the
native and the selenomethionine-substituted forms with resolu-
tions of 3.2 and 3.0 A˚, respectively (Figure 2A). Two copies of
VgrG2bC-ter were found in the asymmetric unit of the crystal,
which could be superimposed with a root-mean-square devia-
tion (RMSD) of 0.1 A˚ (Tables S1 and S2). In solution, however,
the purified metallopeptidase domain exists predominantly as
a monomer, as determined by size-exclusion chromatography-
multi-angle laser light scattering (SEC-MALLS), with a dimeric
species also present (Figure S1A). It is likely that the physiolog-
ically relevant oligomerization state of the metallopeptidase
domain is achieved only in the full-length VgrG2b protein.
The VgrG2bC-ter protomer possesses a single domain
composed of six a helices and three b strands (Figure 2A), form-
ing a shallow bowl with multiple small loops. A PDB search using
the DALI server identified several thermolysin-like metallopepti-
dases as structural homologs of the VgrG2bC-ter effector domain
(Holm and Laakso, 2016). One such metallopeptidase is human
angiotensin-converting enzyme 2 (Z score: 5.0, Ca RMSD of
4.2 A˚ across 105 residues), with the active sites of these proteins
displaying similar architectures (Figure 2B). Although metallo-
peptidases target diverse substrates, the overall core fold of
three a helices (a2, a3, and a5) and two b strands (b2 and b3)
is highly conserved and bears the classical HEXXH catalytic
motif typical of these zinc-dependent enzymes, where X is any
amino acid (Figure 2B).
Indeed, the conformations of the HEXXH residues in our struc-
ture are suggestive of metal ion coordination, and the geometryCell Reports 29, 187–201, October 1, 2019 189
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Figure 3. Phylogenetic Analysis of the VgrG2b Metallopeptidase Domain
(A) Phylogenetic tree of 240 homologs of the VgrG2b metallopeptidase domain constructed using the maximum likelihood method. Clades are colored by
bacterial family, and the branch denoting VgrG2b of P. aeruginosa is labeled with a red arrow. The scale represents the number of residue substitutions per site.
(B) Schematic representation of the domain architecture of various VgrG2b metallopeptidase domain orthologs. The sequence logo shows the conservation of
residues constituting the predicted HEXXH catalytic motif.
(C) Diagram of genetic cassettes encoding VgrG2b metallopeptidase homologs (shown with an asterisk) found within T6SS loci. In each case, the gene encoding
the putative metallopeptidase lies upstream of a small ORF. The VgrG2bC-ter homolog in B. thailandensis is the evolved VgrG BTH_I2697; SARI_02727 of
S. arizonae and ACIAD0053 of Acinetobacter baylyi are predicted cargo effectors, whereas in Alcanivorax dieselolei, B5T_02182 is a putative evolved PAAR
protein.
(D) Schematic of the genetic loci of the vgrG2b satellite islands of P. aeruginosa strains PAO1 and BL21. The site of a possible recombination event suggesting
duplication of the tle3-tli3module within the 30 end of vgrG2b inP. aeruginosaBL21 is shown by dotted lines. The gene encoding the VgrG2bC-ter metallopeptidase
is marked by an asterisk. Scale bar represents 5 kb.suggests that the electron density in the putative metal-binding
site corresponds to a divalent cation such as zinc. To confirm
that VgrG2bC-ter binds zinc, we employed differential scanning
fluorimetry to assess the thermodynamic stabilization of themet-
allopeptidase in the presence of zinc ions. The melting tempera-
ture of the domain increases from 46.3C in the absence of zinc
to a maximum of 55.1C in the presence of an eight-fold excess
of the metal ion (Figure S1B), providing a strong indication of the
binding of zinc to the metallopeptidase. The assigned zinc ion is
coordinated by the two histidine residues of the catalytic triad
and has a third glutamate ligand (E983) at the top of helix a5 (Fig-
ure 2B). These features permit classification of VgrG2bC-ter as a
thermolysin-like gluzincin within the MA(E) metallopeptidase
subclan (Rawlings et al., 2018).190 Cell Reports 29, 187–201, October 1, 2019VgrG2bC-ter Is Part of aWider Family ofMetallopeptidase
Effectors
We assessed the prevalence of the VgrG2bC-ter metallopepti-
dase domain by exploring its phylogenetic distribution. Homolo-
gous metallopeptidases were found throughout the proteo-
bacterial phylum, especially in bacteria possessing a T6SS
(Li et al., 2015) (Figure 3A). Intriguingly, the presence of
VgrG2bC-ter-like proteins in Sphingomonadaceae, which rarely
encode a T6SS, implies that this protein family may have a role
beyond constituting a T6SS effector. Nevertheless, many ortho-
logs are encoded within T6SS gene clusters and are classified as
DUF4157 domain-containing putative metallopeptidases, found
as both putative cargo and specialized effectors. For example,
Burkholderia pseudomallei encodes an evolved VgrG with this
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Figure 4. VgrG2bC-ter Is the Periplasmic
Toxin of an Antibacterial Effector-Immunity
Pair
(A) Intraspecies P. aeruginosa competition assay
between a strain lacking the vgrG2b-PA0261
module and various isogenic attacker strains un-
der H2-T6SS-conducive growth conditions at
25C for 8 h. The competition assay between the
parental strain (PAO1DrsmA) and itself, shown in
gray, is the internal control for competitive parity.
For (A) and (B), the strains used are described in
the text. The values and error bars represent the
mean ± SEM (n = 3 biological replicates). Statis-
tical comparisons undertaken used one-way
ANOVA with Dunnett’s test using the parent
versus prey competition as the comparator (*p <
0.05, **p < 0.01, ***p < 0.001; ns, not significant).
(B) Intraspecies competition assay showing that
PA0261 is the immunity protein for VgrG2bC-ter.
The prey strain produces PA0261 in trans with or
without its native signal peptide (PA0261(no SP))
or harbors the empty vector. The attacker is the
PAO1DrsmA parental strain. See also Figure S2.
(C) Survival of E. coli expressing vgrG2bC-ter or its
catalytically inactive mutant vgrG2bC-ter (E936A).
The proteins are targeted to the periplasm by the
Tat-dependent signal peptide of TorA in the pTat
vector. Ten-fold serial dilutions of cultures (optical
density 600 [OD600] 10
0 to 106) were spotted on
LB agar containing the noted concentrations of
repressor (glucose) or inducer (IPTG for pET28a
and arabinose for pTat) and grown for 24 h.
Image is representative of three independent
experiments.metallopeptidase domain, similar to VgrG2b. Yet in Collimonas
and Alcanivorax species, it is grafted as an extension of a
PAAR protein. Finally, many members of the Enterobacteriaceae
family code for this metallopeptidase as a putative T6SS cargo
effector (Figures 3B and 3C), underscoring the modularity of
T6SS effector proteins.
Further analysis of the distribution of vgrG2b genes uncovered
evidence for a remarkable recombination event in the
P. aeruginosa BL21 strain, in which the tle3-tli3 module is dupli-
cated within the 30 end of the vgrG2b gene (Figure 3D). This has
given rise to a canonical vgrG gene encoding VgrG2b up to its
TTR fold, with the metallopeptidase domain encoded by a sepa-
rate open reading frame (ORF) downstream of the phospholipase
effector-immunity locus. This genetic reorganization also implies
that vgrG genes can acquire or lose their 30 end through recombi-
nation, allowing the exchange of effector domains at the VgrG tip.
This is reminiscent of observations concerning C-terminal toxin
modules in systems such as contact-dependent growth inhibition
(CDI) andRhsproteins (Ruheet al., 2017;Wanget al., 1998).Over-
all, these in silico analyses suggest that VgrG2bC-ter is frequently
associated with proteobacterial T6SS loci and that its secretion
can be achieved via various effector configurations.
VgrG2b-PA0261 Constitutes an Antibacterial Effector-
Immunity Pair
Our bioinformatic analysis of the genetic context of T6SS-asso-
ciated VgrG2bC-ter orthologs revealed intriguing synteny of thiseffector gene with a small ORF, often unannotated and encoded
downstream, such as PA0261 in P. aeruginosa (Figure 1A),
BTH_I2696 in Burkholderia thailandensis, ACIAD0054 in Acine-
tobacter baylyi, SARI_02726 in Salmonella enterica subsp. arizo-
nae, or B5T_02183 in Alcanivorax dieselolei (Figure 3C). The
juxtaposition of these genes is invariable, prompting the hypoth-
esis that P. aeruginosa VgrG2bC-ter may constitute an antibacte-
rial effector-immunity pair with the PA0261 gene product.
Indeed, T6SS effectors whose genes are systematically en-
coded in tandem with a small ORF are frequently found to exert
antibacterial activity, with the adjacent gene encoding its
cognate immunity protein (English et al., 2012; Hood et al.,
2010; Russell et al., 2011).
We engineered a strain lacking the vgrG2b-PA0261 genes and
placed it in competition with the parental strain under conditions
in which the H2-T6SS is active. Whereas competition of
the parent with itself results in competitive parity, the
DvgrG2bPA0261 strain exhibits a significant growth disadvan-
tage (Figure 4A). VgrG2b is responsible for the advantage of
the parental strain, because a DvgrG2b attacker no longer out-
competes the DvgrG2bPA0261 prey. Importantly, the attacker
and prey strains are isogenic; thus, the vgrG2b-PA0261 module
represents the sole difference between these strains. As such,
the prey strain is immune to the action of all other T6SS toxins
such as Tle3, encoded downstream of PA0261 (Figure 1A).
Deletion of tssE2 in the attacker strain, rendering the H2-T6SS
non-functional, restores competitive parity of the prey strain,Cell Reports 29, 187–201, October 1, 2019 191
confirming the H2-T6SS-dependent secretion of VgrG2b (Fig-
ure 4A), whereas complementation of tssE2 on a plasmid
partially restores the growth advantage of the attacker strain.
Furthermore, a P. aeruginosa strain lacking the immunity gene
exhibits a growth defect on solid media, but not in liquid culture,
consistent with contact-dependent delivery by the H2-T6SS
(Figures S2A and S2B).
To assess the role of PA0261 as the immunity protein neutral-
izing VgrG2b-mediated toxicity, we introduced the PA0261 gene
into the DvgrG2bPA0261 strain in trans. Constitutive expression
of PA0261 in the prey strain abolishes the competitive growth
advantage of the attacker, whereas the empty vector provides
no such immunity (Figure 4B). Bioinformatic analysis of the
PA0261 sequence revealed the presence of a putative N-termi-
nal signal peptide, likely directing the protein into the periplasm
(Figure S2C). Provision of PA0261 without the sequence encod-
ing this N-terminal portion (PA0261(no SP)) fails to prevent elim-
ination by the parent (Figure 4B), suggesting that the predicted
extracytoplasmic localization of this protein is needed to
neutralize VgrG2b, similar to the immunity proteins of other
P. aeruginosa periplasmic-acting toxins (Jiang et al., 2016; Rus-
sell et al., 2011).
If PA0261 requires its putative N-terminal signal peptide to act
as an immunity protein, VgrG2bmust elicit its toxicity beyond the
cytoplasmic membrane. We ectopically produced VgrG2bC-ter in
E. coli and targeted the domain to the periplasm by fusing it to an
N-terminal signal peptide from the Tat-dependent substrate
TorA (Palmer and Berks, 2012; Santini et al., 2001). Production
of VgrG2bC-ter is not detrimental to E. coli when the protein re-
mains in the cytoplasm, because this strain grows similarly to
vector control strain (Figure 4C). However, this domain exhibits
acute toxicity when targeted to the periplasmic compartment
by the Tat-dependent signal peptide. Crucially, substitution of
the putative catalytic glutamic acid residue to an alanine
(E936A from HEXXH) renders VgrG2bC-ter non-toxic in the
periplasm, restoring growth. No differences in the levels of
VgrG2bC-ter production are observed between the periplasmic-
targeted toxin and its inactive isoform (Figure S2D), indicating
that the putative enzymatic activity of the VgrG2bC-ter metallo-
peptidase is responsible for toxicity. Mutation of the two histidine
residues (H935A and H939A) coordinating the zinc ion in our
structure also abolish periplasmic toxicity, supporting our desig-
nation of the HEXXH catalytic triad (Figure S2E). Interestingly,
although raising the tonicity of media has been reported to
rescue growth of bacteria producing the periplasmic-acting
T6SS effectors Tse1 and Tse3, the addition of 0.5 M sucrose
does not suppress the growth defect of E. coli producing
VgrG2bC-ter in the periplasm (Russell et al., 2011) (Figure S2F).
This suggests that VgrG2bC-ter may elicit an activity distinct
from the D,L-endopeptidase and muramidase activities of Tse1
and Tse3, respectively (described later).
We sought to determine whether toxicity was displayed by
orthologs of VgrG2bC-ter and expressed the putative T6SS cargo
effector ACIAD0053 from A. baylyi similarly. Surprisingly, induc-
tion of periplasmic-targeted ACIAD0053 expression does not
hamper E. coli growth under identical conditions to that of intoxi-
cation by VgrG2bC-ter (Figure S2G). Nevertheless, reduction of the
osmolarity of the medium (low-salt LB [LB-LS]) to increase bacte-192 Cell Reports 29, 187–201, October 1, 2019rial susceptibility to lysis results in a drastic reduction in growth of
the strain expressing pTat-ACIAD0053. Once more, alanine sub-
stitution of the residues of the catalytic triad (ACIAD0053*) pro-
duces a non-toxic isoform (Figures S2G and S2H). These results
indicate that members of the VgrG2bC-ter metallopeptidase
effector family act as potent periplasmic antibacterial toxins.
Functional Characterization of the PA0261 Immunity
Protein Family
To validate the toxin-immunity relationship of the VgrG2bC-ter-
PA0261 pair, we investigated whether PA0261 could protect
E. coli from VgrG2bC-ter-mediated toxicity. Coexpression of the
immunity gene relieves the growth defect caused by the metal-
lopeptidase (Figure 5A). As a specificity control, we expressed
tli4, encoding the cognate immunity protein of the antibacterial
H2-T6SS-dependent effector Tle4, which was unable to restore
bacterial viability (Jiang et al., 2016). Immunoblot analysis deter-
mined that both immunity proteins are produced (Figure S3A).
This demonstrates that PA0261 is the cognate immunity deter-
minant of the VgrG2bC-ter toxin. Furthermore, the additional
presence of a higher molecular weight band for PA0261-HA is
indicative of the precursor form of a periplasmic protein, sup-
porting the predicted localization of this immunity protein, which
we later confirm (Figures S3A and S5A). We then used far-west-
ern dot blotting (Figure 5B) to investigate whether complex for-
mation with the metallopeptidase domain was the neutralization
mechanism of PA0261. We spotted recombinant VgrG2bC-ter
(Figure S3B) or theC-terminal TTR domain of VgrG4b as bait pro-
teins on nitrocellulose membrane and incubated them with a
bacterial lysate overproducing hemagglutinin (HA)-tagged im-
munity proteins PA0261 or Tli3. Immunoblotting shows that
despite production of both immunity proteins, only PA0261-HA
binds to VgrG2bC-ter, and not to VgrG4bC-ter, suggesting a spe-
cific interaction with the metallopeptidase domain (Figure 5B).
Furthermore, PA0261 binds the inactive metallopeptidase
variant VgrG2bC-ter (E936A), suggesting that the inactive variant
is fully folded (Figures 5B and S3C). This implies that PA0261
neutralizes VgrG2bC-ter through complex formation, as has
been shown for other biochemically characterized T6SS toxin-
immunity pairs (Russell et al., 2011; Shang et al., 2012).
In general, immunity proteins of T6SS toxins display little
sequence identity with their orthologs, likely because of selective
pressure solely on the conservation of toxin binding (Russell
et al., 2012). This phenomenon is also apparent in the PA0261
family; however, a multiple sequence alignment of homologous
immunity proteins revealed the presence of cysteine residues
in partially conserved positions (Figure S4). Because PA0261 is
a predicted periplasmic protein, the conservation of cysteine
residues engenders the hypothesis that disulfide bond formation
may be required for the function of the protein in the oxidizing
environment of this compartment. To begin answering this ques-
tion, we demonstrated through subcellular fractionation that
PA0261 is found in the periplasm when expressed in E. coli (Fig-
ure S5A). We assessed the ability of PA0261 to protect against
the toxicity of periplasmic VgrG2bC-ter in the absence of dsbA,
encoding the major oxidoreductase of the disulfide bond forma-
tion (Dsb) system in E. coli (Figure 5C). The levels of PA0261 in
the DdsbAmutant are greatly diminished, hampering the growth
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Figure 5. PA0261 Is the Cognate Immunity
Protein of VgrG2bC-ter
(A) PA0261 expression prevents intoxication of
E. coli cells producing periplasmic VgrG2bC-ter.
The non-cognate immunity protein Tli4 is used as
a negative control. The values and error bars
represent the mean ± SEM (n = 3 biological repli-
cates). Statistical significance of the difference in
survival compared with the strain under non-
inducing conditions was calculated by one-way
ANOVA followed by Tukey’s multiple comparison
test (**p < 0.01). See also Figures S3.
(B) PA0261 interacts with VgrG2bC-ter in a far-
western dot blot assay. Recombinant VgrG2bC-ter,
its catalytic mutant, or VgrG4bC-ter were spotted
and incubated with E. coli cell lysates containing
HA-tagged PA0261 or Tli3. Purified HA peptide is
an anti-HA antibody binding control. The bottom
panel shows an immunoblot of the lysate input
samples confirming immunity protein production.
See also Figure S3.
(C and D) Disulfide bond formation is required for
PA0261 to efficiently neutralize VgrG2bC-ter. E. coli
strains produce PA0261-HAwith the expression of
pTat or pTat-vgrG2bC-ter in the presence or
absence of the dsbA gene and plated onto solid
media. Measurement of colony size and images of
the spots are shown in (C). A statistically signifi-
cant difference between colony size of strains
producing periplasmic-targeted VgrG2bC-ter or not
was determined by a two-tailed Student’s t test
(n = 4 biological replicates; ***p < 0.001). Immu-
noblotting determines production of VgrG2bC-ter
and the HA-tagged PA0261 proteins in (D), where
lanes have been excised for clarity. The red arrow
shows the position of the VgrG2bC-ter band. See
also Figure S4.of this strain in the presence of VgrG2bC-ter (Figures 5C and 5D).
This indicates that the Dsb system contributes to the protection
of bacterial cells from T6SS-mediated antagonism, in juxtaposi-
tion to a recent study demonstrating that a lack of DsbA in prey
cells can indirectly confer protection against T6SS attack
because of the improper folding of delivered toxins (Mariano
et al., 2018). Crystal structures of immunity proteins such as
those of the Tai4 family have also revealed the presence of disul-
fide bonds, extending the relevance of our observation to other
families of T6SS immunity proteins (Benz et al., 2013; English
et al., 2012; Fukuhara et al., 2018).
In silico examination of putative immunity proteins tomembers
of the VgrG2bC-ter family suggests that like PA0261, they are tar-
geted to the cell envelope. However, the mechanisms of attain-
ing this localization seem to be diverse. In Enterobacteriaceae,
PA0261 homologs are predicted to be lipoproteins (Fig-
ure S5B), whereas ACIAD0054, the putative immunity protein
to ACIAD0053 in A. baylyi, appears to bear hallmarks of an N-ter-
minal transmembrane helix (Figure S4, top line). Irrespective of
these differences, in both cases the bulk of the immunity protein
would be exposed in the periplasm. The second residue
following the lipobox cysteine residue of the predicted immunity
lipoproteins in Enterobacteriaceae is often a glycine, likely direct-
ing the protein to the outer membrane rather than constituting an
avoidance signal for the lipoprotein outer membrane localization(Lol) pathway as described by the +2 rule (Figure S5B) (Narita
and Tokuda, 2017; Yamaguchi et al., 1988). Indeed, membrane
fractionation of the E. coli cell envelope using selective detergent
treatment showed that the PA0261 ortholog from S. arizonae,
SARI_02726, is enriched in the outer membrane fraction (Fig-
ure S5C). Likewise, the A. baylyi ortholog ACIAD0054 was en-
riched in the inner membrane fraction as predicted (Figure S5D).
Determination of the localization of members of this immunity
protein family supports the designation of VgrG2bC-ter-PA0261
as a periplasmic effector-immunity pair while highlighting the di-
versity of strategies employed by the immunity determinants to
gain access to the periplasm, as summarized in Figure S5E.
VgrG2bC-ter Is Bacteriolytic but Does Not Display
Peptidoglycan Hydrolase Activity
Next, we investigated the activity of the VgrG2bC-ter effector
domain. To determine whether VgrG2bC-ter induces growth
arrest or lysis of target bacteria, we employed an outside-in
approach, permeabilizing E. coli cells with a sublethal con-
centration of polymyxin B and measuring whether the toxin re-
duces culture turbidity. Although VgrG2bC-ter (E936A) does not
decrease the turbidity of the suspension, exogenous addition
of lysozyme or VgrG2bC-ter elicits suspension clarification,
thereby showing that the metallopeptidase effector challenges
cell integrity, having gained access to the periplasm (Figure 6A).Cell Reports 29, 187–201, October 1, 2019 193
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Figure 6. VgrG2bC-ter Perturbs Cell Division
(A) Incubation of recombinant VgrG2bC-ter (red), VgrG2bC-ter (E936A) (yellow) and lysozyme (blue) with polymyxin B-permeabilized E. coli cells. A decrease in
turbidity indicates bacterial lysis. Points and error bars represent the mean ± SEM (n = 3 biological replicates). See also Figure S6.
(B) Single-cell analysis of E. coli cell morphology when expressing pTat, pTat-vgrG2bC-ter or pTat-vgrG2bC-ter (E936A). A series of representative fluorescence
microscopy images of bacteria labeled with the membrane dye FM1-43 to highlight the cell exterior at different time points. Scale bar represents 2.5 mm. Image is
representative of three independent experiments.
(C) Localization of membrane blebs mediated by VgrG2bC-ter activity. Using images from three independent time course experiments, typified by those in (B), the
position of the membrane bleb of 230 intoxicated bacteria was plotted as its fraction of the cell length from midcell. The solid and dashed lines show the median
and quartiles, respectively.
(D) VgrG2b delivery by the H2-T6SS results in membrane blebbing. Fluorescent microscopy images show P. aeruginosa strains labeled with FM1-43 either alone
(PAO1DrsmA, PAO1DrsmADtssE2, or PAO1DrsmADvgrG2bPA0261) or in competition (PAO1DrsmA or PAO1DrsmADtssE2 versus PAO1DrsmADvgrG2bPA0261).
Representative images from three independent experiments are shown. Scale bar represents 1 mm.
(E) Localization of the site of membrane blebbing of PAO1DrsmADvgrG2bPA0261 in competition with the parental strain PAO1DrsmA, using the dataset rep-
resented in (D). Here, 147 intoxicated bacteria were analyzed identically to (C).Because this bacteriolytic effector is a periplasmic-acting
metallopeptidase, we reasoned that it might target either the
peptide bonds in the cell wall or a protein within the cell enve-
lope. We probed the action of the toxin toward the bacterial
cell wall with various approaches. In a turbidimetric assay, re-
combinant proteins were incubated with lyophilized Micro-
coccus lysodeikticus as a substrate, but while lysozyme reduces
turbidity, VgrG2bC-ter does not (Figure S6A). Similarly, zymogra-
phy demonstrated that lysozyme produces a zone of clearing in a
stained gel impregnated with purified E. coli sacculi, yet no such
peptidoglycan degradation was apparent for VgrG2bC-ter (Fig-
ure S6B). An analogous assay for crude protease activity was
also used, with a similar negative outcome (Figure S6C). Finally,
quantification of muropeptides released through sacculus hy-
drolysis using high-performance liquid chromatography (HPLC)
revealed that treatment with VgrG2bC-ter does not alter the
composition of either tetrapeptide-rich or pentapeptide-rich
E. coli cell wall preparations (Figures S6D–S6F). Thus, we194 Cell Reports 29, 187–201, October 1, 2019conclude that VgrG2bC-ter does not exhibit peptidoglycan hydro-
lase activity.
VgrG2b Induces Lysis by Apparent Perturbation of Cell
Division
Next, we turned to single-cell analysis of E. coli producing the
periplasmic-targeted metallopeptidase or its inactive variant
from the pTat vector. Bacterial morphology was highlighted by
staining the membranes with the fluorescent dye FM1-43. Over
the course of 2.5 h, no alterations in rod-like E. coli cell shape
were observed in bacteria harboring the empty vector or pTat-
vgrG2bC-ter (E936A). However, production of the active periplas-
mic metallopeptidase causes aberrant cellular morphology
characterized by membrane blebbing, leading to cell rounding
and lysis (Figure 6B). Periplasmic VgrG2bC-ter is still toxic in
high-osmolarity conditions (Figure S2F), suggesting that the
effector does not cause lysis through global weakening of the
cell wall as with Tse1 and Tse3 (Russell et al., 2011). Figure 6C
shows that blebbing predominately originates at midcell, leading
to the cracking of the rod shape before rounding up, suggesting
a defect in cell division similar to observations during b-lactam
antibiotic administration (Chung et al., 2009; Yao et al., 2012).
This observation of site-dependent perturbation in cell shape is
also in opposition to the notion of VgrG2bC-ter exhibiting generic
peptidoglycan hydrolase activity, unless the metallopeptidase
requires a factor or structure specifically localized at the cell
septum for its activation.
To discount the possibility that this phenotype is an
artifact because of toxin overexpression, we monitored the
morphology of P. aeruginosa cells subject to VgrG2b-mediated
killing in competition assays. Upon attack of the susceptible
DvgrG2bPA0261 strain by its parent, we observed similar mem-
brane blebbing, whereas no such morphological aberrations
occurred when the attacker strain lacked a functional H2-T6SS
(DtssE2) (Figure 6D). In addition, when the strainswere incubated
alone, no blebbing occurred. The blebs produced during elimi-
nation of VgrG2b-sensitive prey again localized to the septum,
indicating that the mechanism of killing by the metallopeptidase
domain is similar whether it is delivered by the T6SS or the
effector is artificially targeted to the periplasm (Figure 6E). These
results demonstrate that VgrG2bC-ter-induced blebbing is a
physiologically relevant phenotype and that the target of this
toxin is conserved between E. coli and P. aeruginosa.
Identification of Putative Interacting Partners of
VgrG2bC-ter
Because characterization of the biochemical activity of
VgrG2bC-ter had been unsuccessful, we turned to affinity purifi-
cation-coupled mass spectrometry to investigate the identities
of putative target proteins that interact with the toxin in the peri-
plasm. A tagged inactive VgrG2bC-ter variant was directed to the
periplasm after which cellular proteins were crosslinked in vivo
using dimethyl 3,30-dithiobispropionimidate (DTBP). Affinity puri-
fication pulled down the tagged inactive metallopeptidase and
any crosslinked interaction partners. Three independent repli-
cates of the affinity-purified protein samples were subject to
mass spectrometry analysis to identify candidate interactors of
the metallopeptidase. This preliminary analysis found 89 pro-
teins enriched in the tagged sample dataset compared with
the untagged VgrG2bC-ter control, which were present in at least
two of the three replicates. Of these, just 19 proteins (21.3%)
were found with MASCOT scores (representing the probability
of true identification of the protein) higher than the threshold
set to exclude background noise. Twelve of these 19 proteins
(63.2%) are localized in the cell envelope and were subsequently
considered candidate interactors of VgrG2bC-ter (Table S3).
Three of the four highest-scoring candidates (MltC, PBP5, and
PBP6a) are involved in peptidoglycan biogenesis. This suggests
that the metallopeptidase may perturb the complex machinery,
which maintains the cell wall, inhibiting cell division and produc-
ing the observed blebbing at midcell. If VgrG2bC-ter acts through
interference with peptidoglycan remodeling, it may be through
direct cleavage of these identified target proteins; however, we
cannot exclude that the interaction with periplasmic binding
partners stimulates a putative peptidoglycan hydrolase activity
of the toxin. The periplasmic action of VgrG2bC-ter preventsgrowth of E. coli strains with single deletions in mltC, dacA
(encoding PBP5), or dacC (encoding PBP6a), indicating that
cleavage of one of these enzymes individually is not sufficient
for toxicity (Figure S7).
The dataset is also enriched with lipoproteins (8/12, or 67%),
raising the possibility that VgrG2bC-ter might interact with the
linker region between the acylated cysteine residue of a lipopro-
tein and its main fold, resulting in disruption of its intrinsic local-
ization. We monitored the abundance of two lipoproteins found
in the dataset, MltC and LolB, in bacterial membranes after incu-
bation of purified VgrG2bC-ter or VgrG2bC-ter (E936A) with bacte-
rial lysates. The presence of VgrG2bC-ter elicits a reduction in
membrane-associated MltC or LolB in a manner dependent on
its catalytic activity (Figures 7A and 7B). We examined the distri-
bution of RcsF, an outer membrane lipoprotein that was identi-
fied below the significance cutoff in our pull-down experiments
(Table S3), and found that its levels were also diminished in the
membrane fraction in the presence of the toxin (Figure 7C).
The abundance of the periplasmic protein TEM-1 was unaltered
in this assay (Figure 7D), suggesting that VgrG2bC-ter may prefer-
entially target lipoproteins; specifically, the toxin may cleave lipid
anchors to release lipoproteins from membranes. Because this
assay was conducted with non-physiological levels of both toxin
and tagged lipoproteins, it is not possible to currently state
whether MltC, LolB, or RcsF is a physiological target of VgrG2b
when delivered by the T6SS. In all, our data indicate that the
VgrG2bC-ter metallopeptidase represents a hitherto-undescribed
family of antibacterial T6SS effectors that appear to dysregulate
the cell division process.
DISCUSSION
Previous work has proposed that VgrG2b is an anti-host effector
that subverts the cytoskeleton (Sana et al., 2015). VgrG2b inter-
acts with members of the gTuRC, whereas VgrG2a, sharing
99.5% identity with VgrG2b across its spike and DUF2345 do-
mains, does not, implying that the interaction occurs through
theC-terminal extension of VgrG2b, encompassing the predicted
metallopeptidase domain. The precise function of this domain
was not explored, so it is unclear whether its catalytic activity is
required for invasion. In addition, although ectopic expression
of vgrG2b within host cells enhances P. aeruginosa uptake, it is
possible that other bacterial factors are involved in the mecha-
nism, because the internalization of neither inert particles nor
other bacteriawas shown. For example, other studies have found
thatP. aeruginosa canbe internalizedbynon-phagocyticcells in a
process that requires the H2-T6SS phospholipase effectors PldA
and PldB (Jiang et al., 2014). Interestingly, PldA and PldB also
display antibacterial activity,whichnecessitates a set of immunity
proteins to avoid self-intoxication, and were coined trans-
kingdom effectors (Jiang et al., 2014; Russell et al., 2013). In
this study, we performed an in-depth characterization of VgrG2b
and propose that it is also a trans-kingdom effector.
The identification of a small ORF downstream of genes encod-
ing homologs of the VgrG2bC-ter metallopeptidase family is a key
finding in this work. We demonstrated the impact of the VgrG2b
metallopeptidase domain on bacterial survival when reaching
the periplasm of prey cells in an H2-T6SS-dependent manner.Cell Reports 29, 187–201, October 1, 2019 195
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Figure 7. Incubation with VgrG2bC-ter Re-
duces the Abundance of Lipoproteins in
Bacterial Cell Membranes
(A–C) Immunoblot analysis (left panels) and
densitometry (right panels) of the abundance of
lipoproteins MltC (A), LolB (B), and RcsF (C) in
bacterial total membrane fraction (TMF) prepara-
tions in the presence of recombinant VgrG2bC-ter,
VgrG2bC-ter (E936A), or a buffer-only control.
(D) Abundance of the periplasmic protein TEM-1
was assessed. The outer membrane protein PhoE
acts as a marker of the total membrane fraction,
and RpoB serves as the soluble fraction marker. A
statistically significant difference in protein abun-
dance between incubation with buffer or recom-
binant protein was determined by a two-tailed
Student’s t test (n = 3 biological replicates; *p <
0.05, ***p < 0.001; ns, not significant). See also
Figure S7.The HEXXHmotif in its C-terminal domain had led to its designa-
tion as a putative zinc-dependentmetallopeptidase, and herewe
present the crystal structure of this domain, which confirms this
classification. Our phylogenetic analyses of VgrG2bC-ter-like pro-
teins also find the corresponding genewithin T6SS loci of diverse
proteobacteria. It is frequently annotated as DUF4157, which
corresponds to a small domain of approximately 80 residues en-
compassing the HEXXH motif. Our data show that mutations in
the catalytic site abrogate the antibacterial activity, although
we were unable to identify direct cleavage of a substrate by
VgrG2b.196 Cell Reports 29, 187–201, October 1, 2019Our characterization of VgrG2bC-ter as
an antibacterial toxin is supported by the
recent description of the ACIAD0053 pro-
tein fromA.baylyi (Ringel et al., 2017). This
study showed that anA. baylyi strain lack-
ing ACIAD0053-ACIAD0054 can be elim-
inated by its parent, leading to the desig-
nation of the locus as encoding a type VI
metallopeptidase effector-immunity pair,
Tpe1-Tpi1. We have additionally demon-
strated that similar to VgrG2bC-ter, Tpe1
exerts its activity in the periplasm,
whereas the cognate immunity protein
Tpi1 resides in the inner membrane. The
ortholog of this immunity determinant in
S. arizonae is an outermembrane lipopro-
tein, but in both cases, the bulk of the
immunity protein is exposed to the peri-
plasm; accordingly, we also observe
PA0261 of P. aeruginosa localizing to
this compartment. It is therefore fitting to
propose that the VgrG2bC-ter-PA0261
family of metallopeptidase effector-im-
munity pairs constitutes members of the
Tpe-Tpi family.
In our study, we revealed the differing
ability of VgrG2bC-ter and the A. baylyitoxin Tpe1 to intoxicate E. coli. Work by Ringel and colleagues
demonstrated Tpe1 toxicity in A. baylyi under standard labora-
tory conditions but failed to see an impact on E. coli (Ringel
et al., 2017). We corroborate this observation under standard
laboratory conditions but find that a defect in E. coli growth is eli-
cited by Tpe1 in conditions of low salinity, implying that osmolar-
ity, or salt per se, may regulate its action. Recently, a study of
effector synergy within a delivered payload indicates that condi-
tional efficacy is a common phenomenon among T6SS toxins;
thus, toxin efficiency should be considered in the context of
the whole T6SS-delivered payload (LaCourse et al., 2018;
Shneider et al., 2013). It may be that the biochemical action of
Tpe1 is inhibited by moderate salinity, or rather its target is regu-
lated by this condition. Alternatively, this experimental setupmay
simply reflect a more environmentally relevant condition and
imply that VgrG2bC-ter is amore robust enzyme. Salinity is known
to regulate periplasmic proteins such as peptidoglycan biosyn-
thetic enzymes, presenting the possibility that these toxins
may interact with different members of a family of peptidoglycan
remodeling enzymes such as penicillin-binding proteins (PBPs)
or lytic transglycosylases (LTases) (Mo¨ll et al., 2015; Palomino
et al., 2009). Indeed, P. aeruginosa, A. baylyi, and E. coli possess
differing quotas of these peptidoglycan hydrolases, rendering
species-dependent nuances in substrate targeting an attractive
hypothesis (Dik et al., 2017; Pazos et al., 2017).
We observed bulge formation at sites of septation resulting
from the activity of VgrG2bC-ter. Recently, a T6SS effector inhib-
iting bacterial cell division was described in Serratia proteama-
culans, for which ADP ribosylation of the essential cell division
protein FtsZ prevents Z-ring formation, causing bacterial elonga-
tion because of inhibition of septation (Ting et al., 2018). The cell
division defect mediated by VgrG2bC-ter that we observe ap-
pears to be distinct, characterized by midcell blebbing. This is
reminiscent of the inhibition of the cell wall biosynthesis machin-
eries by b-lactam antibiotics, in which the balance of peptido-
glycan growth and degradation is disrupted, causing severe
morphological aberrations and cell lysis (Cho et al., 2014; Dik
et al., 2019; Templin et al., 1992). Class A PBPs possess trans-
peptidase (TPase) and glycosyltransferase activities to incorpo-
rate new monomers into the sacculus, and these biosynthetic
processes are coordinated with the degradative action of en-
zymes such as LTases, amidases, and carboxypeptidases
(CPases), which modify the peptidoglycan to regulate its growth
and permit septation of daughter cells (Egan et al., 2017). These
enzymes form large complexes, whose subcellular localization
often regulates their activities, and dysregulation of this process
usually results in lysis. For example, the recruitment to midcell
and subsequent activity of the TPase LdtD requires the
concerted actions of PBP5, PBP6a, and PBP1b to facilitate sep-
tation under certain stress conditions, the latter of which is also
associated with LTases MltA and MltG and is recruited to the
septum by the lipoprotein LpoB (Hugonnet et al., 2016; Monto´n
Silva et al., 2018; More` et al., 2019; Paradis-Bleau et al., 2010;
Typas et al., 2010; Vollmer et al., 1999; Yunck et al., 2016). Simi-
larly, perturbation of the localization of EnvC and NlpD to the di-
vision site, which controls the activity of amidases required for
separation of daughter cells, results in septation failure (Tsang
et al., 2017; Uehara et al., 2009, 2010).
Consequently, it is thought that functional redundancy may
help to insulate this crucial process from environmental insults,
and correspondingly, individual deletions in LTases and many
PBP genes often do not produce phenotypic changes, because
the enzymes display partially overlapping functions for robust
control of cell division in changing conditions (Denome et al.,
1999; Heidrich et al., 2002; Pazos et al., 2017; Peters et al.,
2016). Our pull-down assays identified the membrane-associ-
ated LTase MltC and the D,D-CPases PBP5 and PBP6a as
possible interaction partners of VgrG2bC-ter, yet individually
they are dispensable for effector-mediated toxicity, potentiallyas a consequence of built-in redundancy. The precise biochem-
ical activities and functions of these peptidoglycan biosynthetic
enzymes have only started to be unraveled (Artola-Recolons
et al., 2014; Dijkstra and Keck, 1996; Meiresonne et al., 2017;
Peters et al., 2016), so further work is required to establish their
relevance during intoxication by the T6SS.
We found that VgrG2bC-ter depletes several lipoproteins from
membranes, implying broad target specificity by associating
with the lipidated linker region of these proteins. We speculate
that the activity VgrG2bC-ter may disrupt the localization of lipo-
proteins associated with cell envelope maintenance such as
membrane-associated LTases, the cell wall anchoring protein
Lpp, or components of the Lol and Bam machineries, thereby
perturbing bacterial cell division. Targeting of lipidated sub-
strates has been described for bacterial effectors of the type III
secretion system, namely, YopT of Yersinia enterocolitica and
IpaJ of Shigella flexneri. These proteases are delivered into
host cells, where they cleave the isoprenyl and N-myristoyl an-
chors of small guanosine triphosphatases (GTPases), respec-
tively, to disrupt host cell signaling and facilitate bacterial survival
(Burnaevskiy et al., 2013; Shao et al., 2002). Indeed, these effec-
tors target specific families of GTPases during infection, rather
than a single protein; thus, the notion of target promiscuity for
VgrG2bC-ter has an intriguing precedent (Burnaevskiy et al.,
2015; Fueller and Schmidt, 2008).
In summary, we find that besides its described role in invasion
of eukaryotic cells, the evolved VgrG2b spike protein of
P. aeruginosa has a direct role in bacterial antagonism. Given
the vast dissimilarity between host microtubule manipulation
and bacteriolytic activity, reconciliation of VgrG2b metallopepti-
dase dual role warrants further work to shed light on the activity
of this effector within eukaryotic systems. In prokaryotes, the
C-terminal metallopeptidase domain elicits acute toxicity when
targeted to the periplasmic space, resulting in dysregulation of
bacterial morphology and cell lysis. The prevalence of this family
of T6SS effector proteins suggests conservation of its target, so
elucidation of its antibacterial mechanism may help progress
both our knowledge of bacterial cell division and how to target
this process with therapeutic compounds.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial strains were grown at 37C in lysogeny broth (LB) with agitation unless stated otherwise. All cultures were supplemented
with antibiotics and other supplements where necessary. The following antibiotic concentrations were employed for E. coli: 50 mg/ml
kanamycin, 50 mg/ml ampicillin, 50 mg/ml streptomycin, 34 mg/ml chloramphenicol, 15 mg/ml tetracycline, 200 mg/ml trimethoprim and
15 mg/ml gentamicin. For P. aeruginosa, 50 mg/ml gentamicin, 2 mg/ml streptomycin, 50 mg/ml tetracycline and 100 mg/ml carbeni-
cillin were used. Deletion mutants were constructed as previously described (Vasseur et al., 2005). Briefly, splicing by overlap exten-
sion polymerase chain reaction (PCR) was used to generate DNA fragments of regions of the P. aeruginosa genome with in-frame
gene deletions introduced, whichwere cloned into the suicide vector pKNG101. After mobilisation intoP. aeruginosa by three-partner
conjugation from E. coliCC118lpir and with the 1047 pRK2013 helper strain, selection of conjugants was achieved on Vogel-Bonner
medium (20 mM magnesium sulfate heptahydrate, 200 mg anhydrous citric acid, 1 g potassium phosphate dibasic and 350 mg
ammonium sodium phosphate dibasic tetrahydrate) supplemented with 1.5% (w/v) agar and 2 mg/ml streptomycin. Counter-selec-
tion on solid LBmedium containing 20% (w/v) sucrose at ambient temperature for 72 h lead to plasmid excision and generation dou-
ble recombinants. All mutants were confirmed by PCR and sequencing.
METHOD DETAILS
Secretion assays and immunoblot analysis
P. aeruginosa secretion assays were conducted as previously described (Allsopp et al., 2017) with the following modifications. Cul-
tures were inoculated into 25 mL tryptic soy broth (TSB) at OD600 0.1 and grown for 8 h at 25
C with agitation. Supernatants were
cleared of cells by four rounds of centrifugation at 4000 g at 4C, successively taking the uppermost supernatant. Proteins were
precipitated with 10% trichloroacetic acid supplemented with 0.03% sodium deoxycholate overnight at 4C. Separation of protein
samples by SDS-PAGE and subsequent immunoblot analysis was conducted as previously described (Hachani et al., 2011) with the
exception of culture supernatants being loaded at 20x concentrated in comparison to the whole cell extracts.e3 Cell Reports 29, 187–201.e1–e7, October 1, 2019
Here, bacterial culture samples were normalized to anOD600 1.0. Gels containing 6%, 8%, 10%, 12%or 15%polyacrylamidewere
used to separate protein samples by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in Tris-glycine-SDS buffer (0.3% (w/v)
Tris, 1.44% (w/v) glycine, 0.01% (w/v) SDS) at 180 V, depending on the size resolution desired. Gels were prepared using Mini-
PROTEAN Tetra handcast systems (BioRad) and the Precision Plus Protein Kaleidoscope Prestained Protein Standards marker
(Bio-Rad) was loaded to show the migration of molecular weight standards. Samples were stained with Coomassie Brilliant Blue
R250 (Sigma) or subjected to immunoblotting. For immunoblot analysis, protein samples were transferred to 0.2 mm nitrocellulose
membrane (Amersham Biosciences) after incubation in transfer buffer (10% (v/v) Tris-glycine-SDS buffer, 20% (v/v) ethanol) using
a TransBlot SD semi-dry transfer cell (BioRad) at 24 V and 0.18 A for 44 min. Membranes were blocked using a solution of 5%
(w/v) skimmed milk powder (Sigma), 50 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.1% (v/v) Tween-20 for 1 h before the addition
of primary antibodies. Primary antibodies were used at 1/1000 dilutions in blocking buffer overnight at 4C, aside from anti-RpoB
and anti-PhoE, which were used at 1/5000 and 1/2000, respectively. Membranes were washed in blocking buffer lacking milk three
times before the addition of horseradish peroxidase-conjugated secondary antibodies for 45 min at room temperature. Secondary
antibodies were used at 1/5000 dilution. Membranes were once again washed three times before development using SuperSignal
West Pico Chemiluminescent substrate (ThermoFisher) and imaging using a LAS-3000 imager (Fujifilm).
Protein purification
Purification of proteins was performed as described previously (Allsopp et al., 2017). Briefly, E. coli BL21 (lDE3) pET28a-vgrG2bC-ter
or pET28a-vgrG2bC-ter (E936A) were grown in terrific broth at 37
C for 2 h prior to induction of gene expression by addition of 1 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) and growth overnight at 18C. B834 (lDE3) was the host for selenomethionine incorpo-
ration. Cell harvesting and protein purification was done as described, but without protease inhibitors. The C-terminal hexahistidine
tagwas cleaved by thrombin protease (SigmaAldrich) and dialysed into low imidazole buffer (50mMTris-HCl pH 8.0, 500mMsodium
chloride, 20 mM imidazole) before separation from non-cleaved protein on a Ni2+-NTA column in the flow-through fractions. Proteins
were concentrated in AmiconUltra Centrifugal Filter Units (Millipore) before further purification by SEC using a Superdex S200 10/300
GL column (GE Healthcare). Purity of elution fractions was determined by Coomassie staining of proteins separated by SDS-PAGE.
Crystallization experiments and structure determination
Purified VgrG2bC-ter was concentrated to 12mg/ml and centrifuged for 20minutes at 4
C to remove dust and aggregates. The protein
was crystallized by vapor diffusion at 20C,with small crystals growing in 100Mmbis-tris pH 6.5 and 45%polypropylene glycol P400.
Their space group was P31 and they diffracted to 3.2 A˚. The structure was solved by experimental phasing, whereby crystals of se-
lenomethionylated protein were grown in 100 mM sodium citrate pH 4.7, 20 mM magnesium chloride, 50 mM sodium chloride and
29% PEG400. These crystals had space group P4212 and diffracted to 3.0 A˚. Data were collected at the beamlines i02 and i04 of
Diamond Light Source (Didcot, UK) from crystals flash-frozen in liquid nitrogen without additional cryoprotection. Diffraction data
from both experiments can be downloaded from Zenodo (https://doi.org/10.5281/zenodo.3246345). Data were processed in XDS
(Kabsch, 2010). The structure was solved by single anomalous dispersion based on the selenomethionine signal, although due to
limited resolution and low anomalous signal, four datasets were combined in Blend (Foadi et al., 2013) to determine the anomalous
substructure in SHELX (Sheldrick, 2010). A partial model comprising secondary structure elements was built by phenix.autobuild
over several rounds of rebuilding and refinement before being used for molecular replacement with the P31 dataset in Phaser (McCoy
et al., 2007). The new model was rebuilt in Coot and refined in Refmac5 (Murshudov et al., 2011), phenix.refine (Adams et al., 2010)
and Buster-TNT (Blanc et al., 2004) until convergence. The crystallographic statistics are summarized in Table S1. Interface analysis
was performed on the Proteins, Interfaces, Structures and Assemblies (PISA) server while molecular graphics figures were prepared
with PyMol (Schro¨dinger).
Differential scanning fluorimetry
Analysis of the thermal stability of recombinant VgrG2bC-ter protein in the presence and absence of zinc ions was determined using a
Mx3005P qPCR instrument (Agilent). VgrG2bC-ter was used at 1.25 mM, in a buffer of 10 mM HEPES pH 7.4 and 100 mM NaCl sup-
plemented with zinc acetate as indicated. The fluorescent dye SyproOrange (Sigma Aldrich) was used at a 1/1000 dilution and the
thermal unfolding of VgrG2bC-ter was monitored between 25-98
C at a rate of 1.5K/min. Excitation occurred at 492 nm and emission
fluorescence at 610 nmwasmeasured every 40 s. Non-linear least-squares fitting (Kemmer and Keller, 2010) was used to analyze the
raw data and the melting point of each sample was determined from the inflection point of the fitted curve.
SEC-MALLS
The oligomeric state of recombinant VgrG2bC-ter was determined using SEC-MALLS and refractometry. VgrG2bC-ter was loaded onto
a Superdex 75 10/30 column (GE Healthcare) and separated at 20Cwith a flow rate of 0.5 ml/min. MALLS detection was performed
with a miniDAWN TREOS detector (Wyatt Technology) using a laser emitting at 657.3 nm. The refractive index of the solution was
measured with an Optilab T-rEX detector (Wyatt Technology) with the refractive-index increment (dn/dc) set to 0.185 ml/g.
Weight-averaged molar masses were calculated using ASTRA software (Wyatt Technology).Cell Reports 29, 187–201.e1–e7, October 1, 2019 e4
Bacterial competition assays
The P. aeruginosa strains used in intraspecies competitions were differentiated by integration of Mini-CTX-lacZ at the chromosomal
att site of the prey strains, permitting blue/white screening on 5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-gal)-containing
solidmedia. Bacteria were grown overnight in 5mL LBwith appropriate antibiotics before normalization to anOD600 3.0 in 1mL sterile
PBS. Attacker and prey strains were mixed at a 1:1 ratio and 5 ml competition drops were spotted onto dry 3% low salt LB agar (10 g
bactopeptone, 5 g yeast extract, 30 g bacteriological agar per liter). After drying, competitions were incubated at 25C for 24 h. Both
the input and output of competition spots were serially diluted in PBS and plated on LB containing 100 mg/ml X-gal for enumeration of
colony forming units (CFU). The competitive index was calculated as the ratio between the input and output attacker/prey ratios. For
self-intoxication assays on solid media, overnight cultures of P. aeruginosa strains were normalized and spotted onto nitrocellulose
membrane on 3% LB agar containing gentamicin and 300 mM IPTG. CFUs were enumerated after 18 hours of growth at 25C. For the
corresponding growth curves in liquid media, overnight cultures were back-diluted 200-fold into LB broth containing gentamicin and
300 mM IPTG. Cultures were grown at 25C with agitation in a 96-well plate, and OD600 readings were taken every 30 minutes for
18 hours using a Synergy 4 Microplate Reader (Biotek Instruments).
Bacterial intoxication assays
E. coli DH5a was transformed with pTat plasmids harboring variants of T6SS metallopeptidase genes to target the gene products to
the periplasmic space and BL21 (lDE3) was the host when pET28a and pET22b plasmids were used. Investigation into the role of cell
wall biosynthetic enzymes employed the corresponding deletion strains and the BW25113 parent strain from the Keio collection as
hosts (Baba et al., 2006). The host for the peri-vgrG2b(847-1019) plasmids was E. coli XL1-Blue harboring the immunity gene under a
leaky promoter, since the presence of the plasmid containing thewild-type peri-vgrG2b(847-1019) construct was otherwise not toler-
ated. Overnight cultures of the strains harboring the vectors of interest were grown in LB, normalized and serially diluted. Dilutions
were spotted on LB agar containing inducer (100 mM IPTG, 0.2% arabinose or 0.3% rhamnose) or repressor (0.2% glucose). To
modify the osmolality of solid media, low tonicity was achieved with low salt LB agar, while to raise it LB agar was supplemented
with 500 mM sucrose.
Subcellular fractionation of bacterial cells
The localization of proteins within bacterial cells was probed by membrane fractionation and periplasmic extraction procedures. To
extract the periplasm, E. coli cells producing the proteins of interest were normalized to OD600 20 and resuspended in 200 ml sphe-
roplast buffer (200 mM Tris-HCl pH 8.0, 500 mMEDTA, 500 mM sucrose) to which 50 mg hen egg-white lysozyme (Roche) was added
and incubated at 4C for 15 min. To this, 720 ml half-strength spheroplast buffer was added and incubated for a further 15 min to
release the periplasmic contents. Centrifugation at 5000 g at 4C for 5 min separated the spheroplasts from the periplasmic fraction.
To assess the presence of proteins in the inner and outer membranes, E. coli cultures were resuspended in sonication buffer (50 mM
Tris-HCl pH 8.0, 1 mMEDTA) and lysed using a Vibra-Cell sonicator (Sonics &Materials, Inc.) on ice. Centrifugation at 4000 g cleared
the soluble fraction from the cellular debris before ultracentrifugation at 100 000 g for 1 h at 4C pelleted the total membrane fraction.
After washing the membranes with sonication buffer, solubilisation buffer (15 mM Tris-HCl pH 7.4, 2% sodium lauroyl sarcosinate)
was added to differentially solubilise the inner and outer membrane proteins before further ultracentrifugation to pellet the insoluble
outer membrane protein fraction. The membrane fractions were separated, and the pellet was washed with solubilisation buffer. All
fractions were normalized prior to analysis by SDS-PAGE.
Far-western dot blot analysis
Protein-protein interactions were probed by far-western dot blotting as described previously (McCarthy et al., 2017). Briefly, 10 mg
purified protein of interest or HA peptide (Sigma Aldrich) was spotted onto nitrocellulose membrane and air-dried before blocking.
Lysates of E. coli strains producing the prey proteins with C-terminal HA tags were obtained by sonication and normalized to OD600
10 in protein binding buffer (20mMTris-HCl pH 7.6, 100mMsodium chloride, 10%glycerol, 0.1%Tween-20, 2% skimmedmilk pow-
der). Membranes were incubated with the lysates or protein binding buffer overnight at 4C prior to washing three times and immu-
noblotting for the bait and prey proteins.
Turbidometric and colorimetric analysis of VgrG2b activity
Generic protease activity of 10 mg recombinant VgrG2bC-ter, its inactive mutant and a proteinase K control was assessed using 1%
proteinaceous substrates bovine serum albumin and gelatin in 2% bacteriological agar plates. After incubation at 37C for 24 h,
plates were stained with amido black solution (Vermelho et al., 1996) to visualize zones of proteolysis. Lysozyme activity of recom-
binant proteins utilized the lyophilised substrate Micrococcus lysodeikticus (Sigma Aldrich) as previously documented (Lossi et al.,
2011). The polymyxin B-mediated permeabilisation of the bacterial outer membrane to permit access of exogenous proteins to the
periplasmic space was performed as described elsewhere (Brooks et al., 2013), except E. coli was employed. E. coli DH5a was re-
suspended in turbidometry buffer (50 mM Tris-HCl pH 8.0, 150 mMNaCl) at OD600 0.2 and incubated with 4 mg/ml polymyxin B. After
addition of 10 mg purified protein, the turbidity at OD600 was monitored at five-minute intervals for 1 h.e5 Cell Reports 29, 187–201.e1–e7, October 1, 2019
Zymography
Peptidoglycan was purified from 500 mL E. coli MC4100 culture for zymographic analysis as described elsewhere (Brooks et al.,
2013; Santin and Cascales, 2017). Briefly, 10 mg purified protein was separated by SDS-PAGE in gels impregnated with 0.1% pepti-
doglycan before the gel was washed with ddH2O and equilibrated in renaturation buffer (10 mM Tris-HCl pH 7.5, 10 mM zinc acetate,
0.1% Triton X-100). Renaturation of the proteins occurred overnight at 37C and after washing the peptidoglycan was stained with
methylene blue (0.1% methylene blue, 0.01% potassium hydroxide) to visualize zones of clearing corresponding to peptidoglycan
hydrolase activity.
Peptidoglycan hydrolase assay
Peptidoglycan was isolated from E. coli MC1061 (Casadaban and Cohen, 1980) and CS703/1 (Meberg et al., 2001) strains as
described previously (Glauner, 1988). Briefly, E. coli cultures were grown to mid-exponential phase before centrifugation to pellet
the cells. Cell membranes were solubilised by adding the cells in ice-cold water drop-wise into a boiling 8% (w/v) SDS solution under
agitation. After cooling overnight, cell sacculi were collected by centrifugation at 130 000 g for 1 h at room temperature and washed
four times to remove residual SDS. Glycogen and covalently-linked proteins were released by treatment with amylase and pronase,
respectively, before boiling in SDS once more. Purified peptidoglycan was washed four more times in distilled water before resus-
pension in 20 mM sodium phosphate buffer pH 4.8. Reactions were carried out in 50 mM Tris-HCl pH 7.5 containing 150 mM NaCl,
0.05% Triton X-100 and 1mMZnCl2. Purified VgrG2bC-ter or VgrG2bC-ter (E936A) (5 mM) was incubated with 0.1 mg/ml purified pepti-
doglycan in a final volume of 100 ml for 4 h at 37C in a thermoshaker at 850 rpm. Reactions were terminated by boiling the samples at
100C for 10 min. Next, 20 ml of 20 mM sodium phosphate pH 4.8 and 1 mM cellosyl muramidase (kindly provided by Hoechst, Ger-
many) were added and incubated over night at 37C. Samples were centrifuged at 13 000 rpm for 10 min and the supernatant con-
taining the soluble muropeptides was collected. Samples were reduced using sodium borohydride and adjusted to pH 4-5 before
reduced muropeptides were separated by reversed-phase HPLC (Glauner, 1988).
Microscopy techniques
E. coliDH5a harboring pTat plasmids were grown to OD600 0.5, resuspended in LB containing chloramphenicol, 0.2% arabinose and
5 mg/ml FM1-43 lipophilic dye, and 1 ml was spotted onto a coverslip under an agarose pad for microscopic analysis. Growth of bac-
teria was monitored every 30 min in a heated chamber at 37C using an Axio Observer Z1 epifluorescent microscope (Zeiss). Image
processing and cell length measurements were performed with FIJI software. Analysis of P. aeruginosa cell morphology was con-
ducted similarly; however, competitions were initialised as described in the section ‘‘Bacterial competition assays.’’ To investigate
the role of DsbA in PA0261-mediated neutralisation of periplasmic VgrG2bC-ter, E. coli MC1000 or its dsbA mutant derivative
harboring the relevant plasmids were normalized to OD600 1 after overnight growth. Serial dilution followed and spots were plated
on LB agar containing the appropriate antibiotics in inducing or repressing conditions. Images of the spots were acquiredwith a Leica
M205FA stereomicroscope with a 1x objective and colony area measurements were also determined within FIJI software.
Mass spectrometry analysis
Mass spectrometry analysis was conducted by the Plateforme Prote´omique Structurale et Fonctionelle at the Institut Jacques
Monod, Paris. Briefly, samples underwent on-bead digestion with 12.5 mg/ml sequencing-grade trypsin (Promega), before peptide
analysis on an Orbitrap Fusion Tribrid mass spectrometer coupled to an Easy-spray nanoelectrospray ion source and an Easy nano-
LC Proxeon 1000 liquid chromatography system (all Thermo Scientific). Chromatographic separation of the peptides was achieved
by an Acclaim PepMap 100 C18 pre-column and a PepMap-RSLC Proxeon C18 column at a flow rate of 300 nl/min. The solvent
gradient consisted of 95% solvent A (water, 0.1% (v/v) formic acid) to 35% solvent B (100% acetonitrile, 0.1% (v/v) formic acid)
over 98 minutes. An Orbitrap mass spectrometer analyzed the peptides in full ion scan mode, with the resolution set at 120 000
with am/zmass range of 350 - 1550. High energy collision-induced dissociation activation with a collisional energy of 28% permitted
fragment acquisition with the quadruple isolation width of 1.6 Da. The linear ion trap was employed in top-speedmode to acquire the
MS/MS data with a 50 s dynamic exclusion and a 1min repeat duration. Maximum ion accumulation times were set to 250ms for MS
acquisition and 60 ms for MS/MS acquisition in parallelisation mode. A MASCOT search server (Matrix Science, version 2.5.1) was
used in-house to identify the peptides. Here, amass tolerance of 7 ppmwas set for precursor ions and 0.5 Da for fragments. Identified
modifications included acetylation (N-terminal), oxidation (Met) and phosphorylation (Ser, Thr or Tyr), and two missed trypsin cleav-
age sites were permitted. The E. coli SwissProt database (August 2017) was searched using the MS/MS data, while searching the
P. aeruginosa database confirmed the presence of the bait proteins. A false-discovery rate of 1%was determined with the percolator
algorithm, below which the identities of peptides could be assigned.
Analysis of lipoprotein abundance
Overnight cultures of E. coli BL21 (lDE3) harboring pET28a-mltC, -lolB, rcsF or pET22b were back-diluted in LB containing the
appropriate antibiotics and construct expression was induced with 100 mM IPTG at OD600 0.4 for 3 h. Cells were harvested by centri-
fugation at 8 000 g for 3min and resuspended in lysis buffer (100mMTris-HCl pH 7.5, 50mMNaCl, 10 mMzinc acetate) for cell disrup-
tion by sonication. Lysates were clarified of cellular debris by sonication three times at 4 000 g for 15min at 4Cbefore incubation with
10 mg VgrG2bC-ter or VgrG2bC-ter (E936A) at 37
C for 1 h. Ultracentrifugation at 100 000 g for 1 h at 4C separated the soluble andCell Reports 29, 187–201.e1–e7, October 1, 2019 e6
membrane fractions, to which Laemmli buffer was added for subsequent SDS-PAGE and immunoblot analysis. Production of MltC,
LolB and RcsF was monitored using antibodies against the C-terminal hexahistidine tag, while production of TEM-1 from pET22b
was detected using a monoclonal antibody. Densitometry was conducted in FIJI software.
Bioinformatic and phylogenetic analysis
Protein sequences were obtained from the non-redundant NCBI database using the BLASTp algorithm, alignments were done in Jal-
view using MAFTT and sequence logos were generated using the Weblogo server (Crooks et al., 2004; Katoh et al., 2017). The pre-
diction of bacterial lipoprotein signal peptides, type I signal peptides and transmembrane helices was undertaken using LipoP 1.0,
SignalP 4.1 and TMHMM server v2.0, respectively (Krogh et al., 2001; Nielsen, 2017). The search algorithm Jackhmmer (EMBL-EBI)
was used to search for homologs of the VgrG2b metallopeptidase domain. Three iterations querying the UniProtKB database were
conducted, retrieving 240 sequences. Sequences were aligned and MEGA7 was employed for phylogenetic analysis, using the
maximum-likelihood method of tree generation with 1000 bootstrap replicates (Kumar et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical analyses described in this work were conducted using Prism 8.0 software (GraphPad) and the statistical parameters,
including sample sizes (where n indicates the number of independent biological replicates, technical replicates or bacterial cells),
p values and statistical tests performed are indicated in the relevant figure legends. The means of biologically independent replicates
were compared using the following statistical tests: Student’s t test, a one-way ANOVA followed by Dunnett’s or Tukey’s multiple
comparisons tests. The spread is reported with the standard error of themean (SEM), or by themedian and quartiles for pooled single
cell analyses.
DATA AND CODE AVAILABILITY
The accession numbers for the crystal structure and diffraction datasets of VgrG2bC-ter reported in this paper are PDB: 6H56 and
Zenodo: 10.5281/zenodo.3246346, respectively.e7 Cell Reports 29, 187–201.e1–e7, October 1, 2019
